Received: 20 April 2021
Accepted: 25 August 2021
First Online: 7 September 2021
: The University of Massachusetts Medical School Institutional Review Board has approved this study. The study was considered exempt because it was a secondary data analysis using de-identified data (the Minimum Data Set 3.0) under a strict data use agreement with the Centers for Medicare and Medicaid Services.
: Not applicable.
: The authors declare that they have no competing interests.